Ireland· IE-PA-EU/1/03/255/1-3
Ventavis 10 microgram/ml nebuliser solution
A iloprost product containing iloprost trometanol, registered in Ireland by Bayer AG. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Iloprost is registered in 12 of 19 countries.
Countries holding a registration under ATC B01AC11 (iloprost), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Iloprost · ATC B01AC11
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of iloprost costs, country by country.
Normalised to the WHO defined daily dose (0.15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Iloprost · price per daily dose (0.15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$252.43
The record
At a glance
HPRA (Ireland)- Active substance
- Iloprost trometanol
- Manufacturer
- Bayer AG
- Country
- Ireland (IE)
- ATC code
- B01AC11
- ATC class
- Iloprost
- Defined daily dose
- 0.15 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/03/255/1-3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
408 interactions on record for iloprost.
Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iloprost · interactions on record
408 records
- 34 severe
- 274 moderate
- 2 minor
- 96 info
Most severe, free to view
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- DanaparoidB01AB09severe
- TinzaparinB01AB10severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Iloprost in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainILOPROST RAFARM 10 MICROGRAMOS/ML SOLUCION PARA INHALACION POR NEBULIZADORRafarm S.A.
- SwedenIloprost Zentiva 10 mikrogram/ml Lösning för nebulisatorZentiva k.s.
- PolandIloprost ZentivaZentiva, k.s.
- BelgiumVentavis 10 µg/mlBayer
- FinlandIloprost ZentivaZentiva, k.s.
- NetherlandsIloprost RAFARM 10 microgram/ml verneveloplossingRafarm S.A.
- SwitzerlandVentavis, Lösung für einen VerneblerBayer (Schweiz) AG
- NorwayVentavisBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Ilomedin, Iloprost
- Bulgaria · Иломедин
- Czechia · Calovat, Iloprost Zentiva
- Germany · Ilomedin, Iloprost Rafarm
- Denmark · Ilomedin, Iloprost
- Spain · Ilomedin, Iloprost Rafarm
- Finland · Ilomedin
- France · Ilomedine, Iloprost Teva
- United Kingdom (Northern Ireland) · Iloprost Colonis Pharma, Iloprost Galvany Pharma
- Greece · Ilomedin, Iloprost Rafarm
- Hungary · Ilomedin
- Iceland · Ventavis
- Italy · Endoprost, Iloprost Rafarm
- Liechtenstein · Ventavis
- Malta · Iloprost Pharmamentum
- Netherlands · Iloprost Hameln, Iloprost Rafarm
- Norway · Ilomedin, Ventavis
- Portugal · Ilomedin, Iloprost
- Romania · Ilomedin 20
- Sweden · Ilomedin, Iloprost
- Slovenia · Ilomedin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d60eb75e-9309-49fb-9616-531f3bb55a0a GET /v1/drugs/d60eb75e-9309-49fb-9616-531f3bb55a0a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nebuliser solution",
"routes": [
"Inhalation use"
],
"source": "hpra",
"atc_all": [
"B01AC",
"B01AC11"
],
"strength": null,
"pa_number": "EU/1/03/255/1-3",
"substances": [
"Iloprost trometanol"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "16/09/2003",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about iloprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.